Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 7/20 | 0.48 |
| ▸ | HDAC6 | Q9UBN7 | 6/20 | 0.48 |
| ▸ | RIPK1 | Q13546 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20095692 | 0.86 | KLKB1 (0.47) | HDAC1HDAC6RIPK1ALDH1A1 | |
| SCHEMBL24310654 | 0.84 | HDAC1 (0.43) | HDAC1HDAC6 | |
| SCHEMBL24310644 | 0.83 | HDAC1 (0.45) | HDAC1HDAC6ALDH1A1HPGDTP53 | |
| SCHEMBL18366892 | 0.81 | HDAC1 (0.53) | HDAC1HDAC6RIPK1ALDH1A1HDAC7 | |
| SCHEMBL30035995 | 0.80 | HDAC1 (0.52) | HDAC1HDAC6RIPK1ALDH1A1HDAC7 | |
| SCHEMBL751549 | 0.80 | HDAC1 (0.47) | HDAC1HDAC6ALDH1A1HPGDTP53 | |
| SCHEMBL24310610 | 0.80 | CA5A (0.41) | HDAC1HDAC6RIPK1ALDH1A1HPGD | |
| SCHEMBL24310730 | 0.80 | HDAC1 (0.45) | HDAC1HDAC6RIPK1HPGDTP53 | |
| SCHEMBL18366885 | 0.80 | HDAC1 (0.52) | HDAC1HDAC6RIPK1TP53MAPT | |
| SCHEMBL20095588 | 0.79 | RIPK1 (0.49) | HDAC1HDAC6RIPK1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3978492-A1 | BICYCLIC COMPOUND AS RIP-1 KINASE INHIBITOR AND APPLICATION THEREOF | Medshine Discovery Inc. (CN) | 2022-04-06 | — | — | EP | disclosed |